本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tango Therapeutics Inc.

23.78
+0.41001.75%
盤後23.780.00000.00%19:30 EDT
成交量:227.93萬
成交額:5,451.26萬
市值:40.19億
市盈率:-28.31
高:24.63
開:23.72
低:23.19
收:23.37
52周最高:34.39
52周最低:6.38
股本:1.69億
流通股本:1.43億
量比:0.86
換手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
淨資產收益率:-21.34%
總資產收益率:-12.99%
市淨率:3.92
市盈率(LYR):-27.19

資料載入中...

2022/07/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/10

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/09

重要事件披露

8-K - Current report
2021/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/14

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/09/27

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/10

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/20

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/19

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals